# International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/rfa-ai-23-023-international-research-in-infectious-diseases-r01-clinical/  
Official notice: https://www.grants.gov/search-results-detail/347525

> National Institutes of Health offered grants of up to $125,000 to the applicants described in the notice. Applications closed on May 23, 2025.

| Field | Value |
|---|---|
| Opportunity number | RFA-AI-23-023 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | May 23, 2025 |
| Award ceiling | $125,000 |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.855 |

## Who can apply

- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

## What the grant funds

The purpose of this Funding Opportunity Announcement (FOA) is to support applications for high-priority, regionally relevant infectious diseases research by international investigators in resource-constrained countries. Applicant organizations must be headquartered in foreign (non-U.S.) resource-constrained countries (i.e. low-income economies, lower-middle-income economies, and upper-middle-income economies by World Bank Classification). Applicant organizations headquartered in low- and lower-middle income economy countries are particularly encouraged to apply. Eligibility status of applicant organizations will be determined by the World Bank Classification list at the time of application submission.

## Questions people ask

### Is RFA-AI-23-023 still open?

No. It closed on May 23, 2025.

### Who can apply for International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.

### What is the deadline for International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)?

Closed May 23, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $125,000 each.

### Who has been funded under RFA-AI-23-023?

NIH RePORTER lists 19 projects funded under RFA-AI-23-023 in fiscal 2024 to 2026, at 17 institutions. The most were at Institute/Research/Biotechnology FDN, Institute of Molecular /Cellular Biology, Medical Research Council of South Africa.

### Who has won Allergy and Infectious Diseases Research grants before?

The largest recipients over five fiscal years were Fred Hutchinson Cancer Center, Duke University, University of California, Los Angeles. The program made 13,282 awards worth $22 billion in that time.